Subgroup analysis of the 155 Asian HCC patients in the dataset also showed that patients with high SIRT4 expression tended to have better overall survival than patients with low SIRT4 expression (Log-rank p = 0.25) (Fig. 2E), but the difference was not statistically significant. This evidence concerns the gene SIRT4 and hepatocellular carcinoma.